Advertisement
Screener

LIQUIDIA CORPORATION (LQDA) Subsidiaries

LIQUIDIA CORPORATION Subsidiaries

Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (6 lists). Names and jurisdictions are as filed.

  • 2026-03-05: Subsidiary Name under which business conducted; Jurisdiction Liquidia Technologies, Inc..
  • 2026-03-05: Subsidiary Name under which business conducted; Jurisdiction Liquidia PAH, LLC.
  • 2025-03-19: Subsidiary Name under which business conducted; Jurisdiction Liquidia Technologies, Inc..
  • 2025-03-19: Subsidiary Name under which business conducted; Jurisdiction Liquidia PAH, LLC.
Annual report filedSubsidiaryJurisdiction
2026-03-05Name under which business conductedLiquidia Technologies, Inc.
2026-03-05Name under which business conductedLiquidia PAH, LLC
2025-03-19Name under which business conductedLiquidia Technologies, Inc.
2025-03-19Name under which business conductedLiquidia PAH, LLC
2024-03-13Name under which business conductedLiquidia Technologies, Inc.
2024-03-13Name under which business conductedLiquidia PAH, LLC
2023-03-20Name under which business conductedLiquidia Technologies, Inc.
2023-03-20Name under which business conductedLiquidia PAH, LLC
2022-03-17Name under which business conductedLiquidia Technologies, Inc.
2022-03-17Name under which business conductedLiquidia PAH, LLC
2021-03-25Name under which business conductedLiquidia Technologies, Inc.
2021-03-25Name under which business conductedLiquidia PAH, LLC

Similar stocks

Stock NameCountryMarket CapPE Ratio
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
Alkermes plc. (ALKS)$6.844B132.74
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07